Drug lobby group starts ad campaign to defend pricing
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
San Francisco
A TOP pharmaceutical lobbying group is launching an ad campaign to defend drugmakers that have been under fire for their pricing practices.
"We're under pressure and scrutiny like never before," said Jim Greenwood, chief executive officer of the Biotechnology Innovation Organization (BIO). The campaign, called "Innovation Saves", says new drugs can save both lives and costs to the healthcare system. BIO is spending "low to mid-seven digits" on the ads, according to Mr Greenwood, or about US$1 million to US$5 million.
Share with us your feedback on BT's products and services
TRENDING NOW
Autobahn Rent A Car directors declared bankrupt over S$50 million each owed to DBS
Amazon’s MGM Studios gains creative control over ‘James Bond’ franchise
UOB’s Wee Ee Cheong says S$4.9 billion Citi deal ‘paying off’ as Asean push accelerates
In taxing wealth, how far can Singapore push property owners?
